Sustained partial remission of metastatic pancreatic cancer following systemic chemotherapy with gemcitabine and oxaliplatin plus adjunctive treatment with mistletoe extract

Onkologie

Volumn 33, Issue 11, 2010, Pages 617-619

  Ritter, Peter R ^a,c   Tischoff, Iris ^b   Uhl, Waldemar ^c   Schmidt, Wolfgang E ^a   Meier, Juris J ^a  

^a St Josef Hospital   (Germany)

^b Department of Pathology ^*  (Australia)

^c ST JOSEF HOSPITAL   (Germany)

Author keywords

Chemotherapy; Mistletoe extracts; Pancreatic carcinoma; Prognosis; Remission

Indexed keywords

CA 19-9 ANTIGEN; GEMCITABINE; OXALIPLATIN; VISCUM ALBUM EXTRACT;

ADJUVANT THERAPY; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HOMEOPATHY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MULTIPLE CYCLE TREATMENT; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; UNSPECIFIED SIDE EFFECT;

ADENOCARCINOMA; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DEOXYCYTIDINE; FEMALE; HUMANS; LYMPHATIC METASTASIS; MISTLETOE; ORGANOPLATINUM COMPOUNDS; PANCREATIC NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS; TREATMENT OUTCOME;

EID: 78049451177     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321133     Document Type: Article

References (10)

1. Warshaw AL, Fernandez-del Castillo C: Pancreatic carcinoma. N Engl J Med 1992;326:455-465.
2. Stathis A, Moore MJ: Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol 2010;7:163-172.
3. Moore M: Activity of gemcitabine in patients with advanced pancreatic carcinoma. A review. Cancer 1996;78(suppl 3):633-638.
4. Louvet C, Labianca R, Hammel P, et al.: Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. J Clin Oncol 2005;23:3509-3516.
5. Ostermann T, Raak C, Bussing A: Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review. BMC Cancer 2009; 9:451.
6. Ernst E, Schmidt K, Steuer-Vogt MK: Mistletoe for cancer? A systematic review of randomised clinical trials. Int J Cancer 2003;107:262-267. (Pubitemid 37152907)
7. Matthes H, Friedel WE, Bock PR, Zanker KS: Molecular mistletoe therapy: friend or foe in established anti-tumor protocols? A multicenter, controlled, retrospective pharmaco-epidemiological study in pancreas cancer. Curr Mol Med 2010;10:430-439.
8. Horneber MA, Bueschel G, Huber R, Linde K, Rostock M: Mistletoe therapy in oncology. Cochrane Database Syst Rev 2008;CD003297.
9. Rostock M, Huber R, Greiner T, et al.: Anticancer activity of a lectin-rich mistletoe extract injected intratumorally into human pancreatic cancer xenografts. Anticancer Res 2005;25:1969-1975.
10. Elluru SR, van Huyen JP, Delignat S, et al.: Induction of maturation and activation of human dendritic cells: a mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancer. BMC Cancer 2008;8:161.